secretariat@msr.my
  • MyMSR Member Login
Malaysian Society of RheumatologyMalaysian Society of RheumatologyMalaysian Society of RheumatologyMalaysian Society of Rheumatology
  • Home
  • About MSR
    • President’s Message
    • Committee Members 2024 – 2026
    • Past Committee Members
      • Committee 2022 – 2024
      • Committee 2020 – 2022
      • Committee 2018 – 2020
      • Committee 2016 – 2018
      • Committee 2014 – 2016
      • Committee 2012 – 2014
      • Committee 2010 – 2012
      • Committee 2008 – 2010
      • Committee 2006 – 2008
      • Committee 2004 – 2006
    • History of MSR
    • Objective & Vision
  • Membership
    • Member Application Form
  • Events
  • SIG
    • About MSR-TUI
    • About MyR
  • Education Resources
    • Patients Information
      • Patient Information Sheet
      • Patient Support Groups
    • General Rheumatology Disease Information
    • Clinical Practice Guidelines
      • Myths & Facts
      • Treatment
      • FAQ
    • Useful Medical Links
  • MyMSR
    • Member Account
    • MSR Constitution
    • AGM/EGM Meeting Reports
    • Rheumatology Subspecialty Training and Accreditation (Revised Feb 2022)
    • Scholarship & Bursary
    • List of Members
    • Claim Forms
    • MSR – TUI
      • MSR-TUI Meeting Minutes
    • NIAR-MARBLE
    • NIAR & MARBLE Report

Drugs For Arthritis: Hydroxychloroquine

    Home Patient Information Sheet Drugs For Arthritis: Hydroxychloroquine

    Drugs For Arthritis: Hydroxychloroquine

    By Neudimenxion | Patient Information Sheet | Comments are Closed | 19 September, 2014 | 0

    Why am I prescribed hydroxychloroquine?

    Hydroxychloroquine is an anti-malarial drug which is used in the treatment of inflammatory arthritis and connective tissue diseases such as systemic lupus erythematosus (SLE). In rheumatoid arthritis, it reduces inflammation in your joints and makes the disease less active, so reducing pain, swelling and stiffness of joints. In SLE, it helps to reduce skin rash. However, it does not work immediately and may take 12 weeks before you begin to notice an improvement, or up to 6 months to have a full effect.

    How do I take the tablets?

    Hydroxychloroquine is available as 200mg tablets. Your doctor will advise you on the dose that is required. It may be 200-400mg per day. The dose of hydroxychloroquine will be adjusted according to the response of your disease. The tablets should be taken with food. Hydroxychloroquine is not a pain killer and you should continue your anti-inflammatory drugs and/or painkillers unless your doctor advises otherwise.

    What are the possible side effects?

    Side effects are uncommon. Some patients develop skin rashes, nausea, diarrhoea or headaches and you should inform your doctor if any of these occur. A baseline eye assessment will be performed because very rarely hydroxychloroquine can affect the vision in patients who take hydroxychloroquine. Should you have any changes in your eye sight you should report to your doctor immediately and stop taking the tablets.

    Does it affect pregnancy?

    Hydroxychloroquine may harm the unborn child. If you are pregnant or breast feeding or planning a family, it is important to discuss this with your doctor.

    Can I take other medicines along with hydroxychloroquine?

    Most medicines can be taken safely at the same time, but always make sure your doctor knows about other drugs you are taking, including any you buy from the pharmacy. If you take indigestion tablets or liquids, take your hydroxychloroquine later in the day.

    Please ask your doctor if you have any further questions.

    No tags.

    Recent Posts

    • Explaning Rheumatoid Arthritis
    • MyNIAR Axial Spondyloarthritis
    • Shingrix Launch
    • RHyME Workshop (Ipoh)
    • 2024 Symposium Unravelling Complexity in SLE & EGPA

    MSR

    The Malaysian Society of Rheumatology was registered with the Registrar of Societies on 7th August 1989, following which the Protem Committee was dissolved and a new official executive committee was elected. MSR soon gained recognition and was warmly welcomed by regional Rheumatology bodies, namely, the Rheumatology Association of ASEAN (RAA) and the Asia Pacific League of Associations for Rheumatology (APLAR). MSR began to actively participate in the activities of these organisations.

    Contact Us

    Malaysian Society of Rheumatology(MSR)
    A-2-15, Block A, Merchant Square @ Tropicana
    No 1, Jalan Tropicana Selatan, PJU 3,
    47410 Petaling Jaya,
    Selangor Darul Ehsan, Malaysia

    Email: secretariat@msr.my

    Map

    • Terms & Conditions
    • Privacy Policy
    • Disclaimer
    • Contact
    © Copyright 2025 Malaysian Society of Rheumatology (MSR) www.msr.my. All Rights Reserved. | Website managed by Neudimenxion
    • MyMSR Member Login
    • Home
    • About MSR
      • President’s Message
      • Committee Members 2024 – 2026
      • Past Committee Members
        • Committee 2022 – 2024
        • Committee 2020 – 2022
        • Committee 2018 – 2020
        • Committee 2016 – 2018
        • Committee 2014 – 2016
        • Committee 2012 – 2014
        • Committee 2010 – 2012
        • Committee 2008 – 2010
        • Committee 2006 – 2008
        • Committee 2004 – 2006
      • History of MSR
      • Objective & Vision
    • Membership
      • Member Application Form
    • Events
    • SIG
      • About MSR-TUI
      • About MyR
    • Education Resources
      • Patients Information
        • Patient Information Sheet
        • Patient Support Groups
      • General Rheumatology Disease Information
        • Myths & Facts
        • Treatment
        • FAQ
      • Clinical Practice Guidelines
      • Useful Medical Links
    • MyMSR
      • Member Account
      • MSR Constitution
      • AGM/EGM Meeting Reports
      • Rheumatology Training
      • Scholarship & Bursary
      • List of Members
      • Claim Forms
      • MSR – TUI
        • MSR-TUI Meeting Minutes
      • NIAR-MARBLE
      • NIAR & MARBLE Report
    Malaysian Society of Rheumatology